{"uid":"cap_Jpb_w2R4olz6rtT2_ayZl","slug":"cn-earnings-pharma-9898b2d5","name":"cn-earnings-pharma","description":"A股医药财报+AI解读 — 12家A股医药龙头(恒瑞医药/迈瑞医疗/药明康德/片仔癀等化药-器械-中药-生物制品营收前12): 营收净利同比+环比、毛利率、ROE、现金流, 中文AI解读, 板块景气概览。","url":"https://agentdatum.com/api/v1/d/cn-earnings-pharma","method":"GET","headers":{},"bodySchema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"type":"object","required":[],"properties":{}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}},"responseSchema":null,"example":null,"exampleRequest":null,"tags":["x402"],"displayCostAmount":"0.01","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"probe","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$0.01/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.01","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.01","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_1Sr-im-DxynCLRuOKBGdL","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"0.01","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Returns financial earnings data and AI-generated Chinese analysis for the top 12 A-share pharmaceutical companies, including revenue, net profit growth rates, gross margin, ROE, and cash flow.","exampleAgentPrompt":"Pull the latest earnings data for the top 12 A-share pharmaceutical companies — I want to see revenue and net profit YoY/QoQ growth, gross margin, ROE, cash flow, and a Chinese AI interpretation of how the sector is doing overall.","exampleUseCases":[{"title":"医药板块季报投研简报","prompt":"帮我查一下A股医药龙头最新季报，重点看恒瑞医药、迈瑞医疗、药明康德的营收净利同比变化和毛利率，再给我一个板块整体景气判断。"},{"title":"China pharma sector due diligence","prompt":"I'm evaluating Chinese pharma stocks — can you get me the latest earnings for the top 12 A-share pharmaceutical names, including their gross margin, ROE, and cash flow trends, with an AI summary in Chinese?"},{"title":"医药股ROE与现金流横向对比","prompt":"帮我对比一下A股前12家医药龙头的ROE和经营现金流，看看哪几家基本面最扎实，顺便给个中文解读。"}],"resultDescription":"Returns structured financial metrics for 12 leading A-share pharmaceutical companies (covering chemical drugs, medical devices, traditional Chinese medicine, and biologics) including: revenue and net profit with YoY and QoQ growth rates, gross margin, ROE, cash flow figures, Chinese-language AI interpretation of each company's results, and a sector-level sentiment/prosperity overview.","failureModes":["Payment failure via x402 protocol results in 402 status and no data returned","Stale data if upstream earnings sources have not refreshed post-reporting period","No query parameters supported so filtering by individual company is not possible","Service may return empty or partial data during earnings blackout periods between reporting seasons"],"whenToPreferThis":"Choose this endpoint when you need a pre-aggregated, AI-interpreted snapshot of Chinese A-share pharmaceutical sector earnings in one call, covering all major sub-sectors (chemical drugs, devices, TCM, biologics) without needing to query individual company APIs. It is especially useful for agents operating in Chinese-language financial research contexts where natural-language AI interpretation in Chinese is required alongside raw financials. Prefer alternatives if you need real-time tick data, non-pharma sectors, or earnings for companies outside the top-12 A-share pharma universe.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-09-15T01:04:50.659Z","isFirstParty":false}